Raymond James Financial
RYTM icon

Raymond James Financial’s Rhythm Pharmaceuticals RYTM Stock Holding History

Raymond James Financial’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.45M Buy
58,069
+8,149
+16% +$737K ﹤0.01% 2542
2026
Q1 		$4.34M Buy
49,920
+8,805
+21% +$856K ﹤0.01% 2707
2025
Q4 		$4.4M Sell
41,115
-2,978
-7% -$316K ﹤0.01% 2623
2025
Q3 		$4.45M Buy
44,093
+33,547
+318% +$3.11M ﹤0.01% 2537
2025
Q2 		$666K Buy
+10,546
New +$646K ﹤0.01% 3829
2025
Q1 		– Sell
-3,892
Closed -$218K – 4932
2024
Q4 		$218K Buy
+3,892
New +$215K ﹤0.01% 4363

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Raymond James Financial's RYTM Position: Q2 2026 in Review

Raymond James Financial increased its Rhythm Pharmaceuticals (RYTM) stake by 16% in Q2 2026, buying an estimated $737K and bringing the position to 58,069 shares worth $6.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2542.

Raymond James Financial first reported a position in RYTM in Q4 2024 and has held it in 6 quarters since. 305 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Raymond James Financial held 58,069 shares of Rhythm Pharmaceuticals worth $6.45M as of Q2 2026.
  • Raymond James Financial bought 8,149 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $737K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2542 holding.
  • Raymond James Financial first reported a position in Rhythm Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 305 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.